Background: GFM2 and Mitochondrial Translation

GFM2 (also known as EF-G2mt or mitochondrial elongation factor G2) is a nuclear-encoded GTPase that localizes to the mitochondrial matrix. It plays an essential role in the elongation phase of mitochondrial protein synthesis by catalyzing the translocation of peptidyl-tRNA from the A-site to the P-site of the mitochondrial ribosome, coupled with GTP hydrolysis.

Deficiencies in GFM2 have been associated with severe mitochondrial diseases, including infantile encephalopathy and combined oxidative phosphorylation deficiency. As a recombinant protein, GFM2 is a valuable tool for studying mitochondrial translation mechanisms, screening inhibitors, and investigating the molecular basis of mitochondrial disorders.

Note: Specific molecular weight, purity grade, and expression host details should be confirmed against the current product datasheet (SKU: rp375576) available from Aladdin Scientific.

Materials Required

• Recombinant Human GFM2 Protein (SKU: rp375576)
• Sterile, nuclease-free water or recommended reconstitution buffer (consult datasheet)
• Low-protein-binding microcentrifuge tubes (1.5 mL)
• Micropipettes and calibrated tips
• Ice bucket or cooling block
• Microcentrifuge
• Appropriate assay buffer (e.g., GTPase assay buffer: 50 mM HEPES pH 7.4, 100 mM NaCl, 5 mM MgCl₂, 1 mM DTT)
• GTP substrate (for activity assays)
• BSA (carrier protein, optional, for dilution stability)

Important: Always consult the current product-specific datasheet supplied with SKU rp375576 for validated reconstitution volumes, buffer compositions, and working concentration ranges prior to beginning any experiment.

Step-by-Step Reconstitution and Handling Protocol

Step 1 – Preparation

Remove the vial from -20°C or -80°C storage and allow it to equilibrate to room temperature for 10–15 minutes. Do not use a heat source to accelerate thawing. Briefly centrifuge the vial (1,000 × g, 10 seconds) to pellet any material adhering to the cap or walls.

Step 2 – Reconstitution

Add the volume of sterile reconstitution buffer specified in the product datasheet directly to the lyophilized cake. Gently pipette up and down to dissolve; do not vortex, as shear forces can denature the protein. Allow the solution to stand for 5 minutes at room temperature if complete dissolution is not immediate.

Step 3 – Aliquoting

Divide the reconstituted protein into single-use aliquots using low-protein-binding tubes. This prevents activity loss from repeated freeze-thaw cycles. Label each aliquot with date, concentration, and lot number.

Step 4 – Storage

Store aliquots at -80°C for long-term use (up to 12 months; verify with datasheet). For short-term use within 1 week, storage at -20°C is acceptable. Avoid repeated freeze-thaw cycles; each cycle may reduce protein activity significantly.

Step 5 – Working Dilutions

Prepare working dilutions immediately before use in an appropriate assay buffer. Adding a carrier protein (e.g., 0.1% BSA) to dilution buffers can help maintain stability at low protein concentrations. Consult the datasheet for recommended working concentrations specific to your assay format.

Quality Control and Troubleshooting

Purity verification: Confirm protein purity by SDS-PAGE prior to use. The expected band should appear at the molecular weight stated on the datasheet. Presence of additional bands may indicate degradation or aggregation.

Activity confirmation: Where applicable, validate GTPase activity using a colorimetric or fluorescence-based phosphate-release assay. Activity should fall within the range specified on the certificate of analysis (CoA).

Common issues and remedies:

• Precipitation: If precipitation is observed after reconstitution, centrifuge at 10,000 × g for 5 minutes and collect the supernatant. Precipitate may indicate protein aggregation due to incorrect buffer or excessive concentration.
• Reduced activity: Check that GTP substrate is fresh, MgCl₂ is present, and that the protein has not been subjected to repeated freeze-thaw cycles.
• Inconsistent results: Ensure all reagents are equilibrated to assay temperature before use and that pipetting technique is consistent.

Safety, Disposal, and Regulatory Notes

Safety: Recombinant Human GFM2 Protein is intended for in vitro research use only. It is not approved for human or veterinary diagnostic or therapeutic use. Handle as a potential biohazard following your institution's biosafety guidelines. Wear appropriate personal protective equipment (PPE): gloves, lab coat, and eye protection.

Disposal: Dispose of all protein solutions and contaminated materials in accordance with local institutional and governmental regulations for biological waste.

Regulatory: This product is for research use only (RUO). It has not been evaluated by the FDA or equivalent regulatory bodies for safety or efficacy in any clinical application. Users are responsible for ensuring compliance with all applicable regulations in their jurisdiction.